MEDVi QUAD is a compounded sublingual ED product. Cialis is tadalafil as an approved finished tablet. Both involve a long-acting PDE5 story; only Cialis has that story on an FDA label for the finished tablet.
Is It Better than Cialis?
Only if extra ingredients and telehealth wrapping solve a problem tadalafil alone did not, and only if you accept compounded-combo uncertainty. For weekend flexibility, labeled tadalafil is the evidence-based long window. For a desire-plus-flow experiment, clinicians sometimes discuss add-on mechanisms, still not a QUAD combo approval.
| Dimension | Cialis / generic tadalafil | MEDVi QUAD |
|---|---|---|
| Approval | Finished drug, ED labels including daily option | Compounded 4-in-1, not combo-approved |
| Duration talk | Up to 36 hours on tadalafil labeling discussions | Marketing borrows that halo; combo not separately labeled |
| Daily use | A real labeled pathway at specific doses | Not something to copy from Cialis.com onto QUAD |
| Cost pattern | Generic tadalafil often inexpensive | Monthly kit pricing near $114–$179 in 2026 promotions |
vs Viagra · how long QUAD lasts · review
Sources Checked for This Page
- FDA warning letter MEDVi, LLC dba MEDVi, 721455, 20 February 2026.
- FDA product labels for sildenafil, tadalafil, and bremelanotide (Vyleesi).
- Brand-facing MEDVi pages and 2026 secondary reporting on the QUAD formula and list prices.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines.